Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Western Ontario

$25,000.00

Scale-up of FAST protein production

EF 2013-14

Résumé
Innovascreen Inc. (New Glasgow, NS) has recently developed an advanced liposomal drug delivery technology- Fusogenix Platform that enhances the intracellular delivery of chemotherapeutics. This technology is based on""insertion"" of fusion-associated small transmembrane (FAST) protein into the liposomal bilayer. Theproduction of the protein is carried out in insect-cell cultures. Currently Innovascreen cultivates insect cells insmall-scale shake-flasks. In order to move towards commercialization of the process it is necessary to producelarger quantities of the protein. The collaborative work proposed here will scale-up the current process inhighly controlled bioreactors and generate the data necessary to predict process performance at pilot-scale(150L).
Programme
Engage Grants Program
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
449586-2013
Name nom
Rehmann, Lars
Department département
Chemical and Biochemical Engineering
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Scale-up of FAST protein production
Keyword
NSERC
Application summary
Innovascreen Inc. (New Glasgow, NS) has recently developed an advanced liposomal drug delivery technology- Fusogenix Platform that enhances the intracellular delivery of chemotherapeutics. This technology is based on""insertion"" of fusion-associated small transmembrane (FAST) protein into the liposomal bilayer. Theproduction of the protein is carried out in insect-cell cultures. Currently Innovascreen cultivates insect cells insmall-scale shake-flasks. In order to move towards commercialization of the process it is necessary to producelarger quantities of the protein. The collaborative work proposed here will scale-up the current process inhighly controlled bioreactors and generate the data necessary to predict process performance at pilot-scale(150L).